Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions

Haematologia

Volumn 29, Issue 1, 1998, Pages 1-11

  Sandler, S G ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alloimmunization; Human leukocyte antigen (HLA); Human platelet antigen (HPA); Platelets; Thrombocytopenia

Indexed keywords

AMINOCAPROIC ACID; DESMOPRESSIN; GLUCOCORTICOID; IMMUNOGLOBULIN; THROMBOCYTE ANTIGEN;

ALLOIMMUNIZATION; APLASTIC ANEMIA; BLEEDING; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CANCER PATIENT; HEMATOPOIETIC SYSTEM TUMOR; HLA TYPING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANEMIA, APLASTIC; ANTIGENS, HUMAN PLATELET; BLOOD DONORS; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; PLATELET TRANSFUSION;

EID: 0031814071     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. McFarland, J. G., Anderson, A. J., Slichter, S. J.: Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Br. J. Haematol. 73, 380 (1989).
2. Murphy, M. F., Metcalfe, P., Ord, J., Lister, T. A., Waters, A. H.: Disappearance of HLA and platelet-specific antibodies in acute leukemia patients alloimmunized by multiple transfusions. Br. J. Haematol. 67, 255 (1987).
3. Dutcher, J. P., Schiffer, C. A., Aisner, J., Wiernik, P. H.: Long term followup of patients with leukemia receiving platelet transfusions. Identification of a large group of patients who do not become alloimmunized. Blood 58, 1007 (1981).
4. Howard, J. E., Perkins, H. A.: The natural history of alloimmunization to platelets. Transfusion 18, 496 (1978).
5. O'Connell, B., Lee, E. J., Schiffer, C. A.: The value of 10-min post-transfusion platelet counts. Transfusion 29, 66 (1988).
6. Slichter, S. J.: Principles of platelet transfusion therapy. In: Hematology/Basic Principles and Practice, 2nd edn, 1987-2006, Hoffman, R., Benz, E. J., Shattil, S. J., Turie, B., Cohen, H. J., Silberstein, L. E. (Eds), Churchill Livingstone, New York (1995).
7. Murphy, W. G., Palmer, J. P., Green, R. H. A.: The management of haemorrhage in the refractory non-alloimmunized thrombocytopenic patient. Vox Sang. 67, 99 (1994).
8. Friedberg, R. C., Donnelly, S. F., Boyd, J. C., Gray, L. S., Mintz, P. D.: Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 81, 3428-3434 (1993).
9. Fanning, J., Hilgers, R. D., Murray, K. P., Bolt, K., Aughenbaugh, D. M.: Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers. Gynecologic Oncology 59, 191-193 (1995).
10. Gmur, J., Burger, J., Schanz, U., Fehr, J., Schaffner, A.: Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 338, 1223-1226 (1991).
11. Aderka, D., Praff, G., Santo, M., Weinberger, A., Pinkhas, J.: Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy. Am. J. Med. Sci. 291, 147-151 (1986).
12. Olsen, K. E., Sandler, S. G.: Febrile neutropenia contributes to underreporting of potential septic platelet transfusions reactions. Vox Sang. 70, 118 (1996).
13. MacPherson, B. R., Hammond, P. B., Maniscalco, C. A.: Alloimmunization to public HLA antigens in multi-transfused platelet recipients. Ann. Clin. Lab. Sci. 16, 38 (1986).
14. McGrath, K., Wolf, M., Bishop, J., Veale, M., Ayberk, H., Szer, J., Cooper, I., Whiteside, M.: Transient platelet and HLA antibody formation in multitransfused patients with malignancy. Br. J. Haematol. 68, 345-350 (1988).
15. Aster, R. H.: Platelet-specific alloantigen systems: history, clinical significance and molecular biology. In: Alloimnmnity 1993 and Beyond, 83-116, Nance, S. T. (Ed.), American Association of Blood Banks, Bethesda, Maryland (1993).
16. A2) and multiple HLA antibodies. Transfusion 28, 597-600 (1988).
17. a involved in platelet transfusion refractoriness in a Japanese man. Vox Sang. 56, 283-287 (1989).
18. Uhrynowska, M., Żupańska, B.: Platelet-specific antibodies in transfused patients. Eur. J. Haematol. 56, 248-251 (1996).
19. Novotny, V. M. J., van Doom, R., Witvliet, M. D., Class, F. H. J., Brand, A.: Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood 85, 1736-1741 (1995).
20. Sintnicolaas, K., van Prooyen, M. C., van Marwijk Koon, M., van Dijk, B. A., van Putten, W. L. J., Novotny, V. M. J., Brand, A.: Leukocyte depletion of random single donor platelet transfusions does not prevent secondary HLA-alloimmunization: a randomized study. Blood 85, 824-828 (1995).
21. von dem Borne, A. E. G. Kr., Simsek, S., van der Schoot, C. E., Goldschmeding, R.: Platelet and neutrophil alloantigens: their nature and role in immune-mediated cytopenias. In: Immunobiology of Transfusion Medicine, 151, Garratty, G. (Ed.), Marcel Dekker, New York (1994).
22. Terasaki, P. I., Bernoco, D., Park, M. S., Ozturk, G., Iwaki, Y.: Microdroplet testing for HLA-A, B, C and D antigens. Am. J. Clin. Pathol. 69, 103 (1978).
23. Rachel, J. M., Sinor, L. T., Tawfik, O. W., Summer, T. C., Beck, M. L., Bayer, W. L., Plapp, F. V.: A solid-phase red cell adherence test for platelet crossmatching. Med. Lab. Sci. 42, 194 (1985).
24. Kim, H. O., Kennedy, S. D., Kickler, T. S.: Studies using immobilized platelet glycoproteins for detection of platelet antibodies. Am. J. Clin. Pathol. 104, 258-263 (1995).
25. Yankee, R. A., Grumet, F. C., Rogentine, G. N.: Platelet transfusion therapy: the selection of compatible donors for refractory patients by lymphocyte HLA typing. N. Eng. J. Med. 281, 1208 (1969).
26. Duquesnoy, R. J., Filip, D. J., Rodey, G. E., Rimm, A. A., Aster, R. H.: Successful transfusion of platelets "mismatching" for HLA antigens to alloimmunized thrombocytopenic patients. Am. J. Haematol. 2, 219 (1977).
27. Rodey, G. E., Neylan, J. F., Whelchel, J. D., Revels, K. W., Bray, R. A.: Epitope specificity of HLA class I alloantibodies. Human Immunology 39, 272-280 (1994).
28. Gelb, A. B., Leavitt, A. D.: Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 37, 624-630 (1997).
29. Friedberg, R. C., Donnelly, S. F., Mintz, P. D.: Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients. Transfusion 34, 215-220 (1994).
30. Lee, E. J., Schiffer, C. A.: ABO compatibility can influence the results of platelet transfusion: results of a randomized trial. Transfusion 29, 384 (1989).
31. Duquesnoy, R. J., Anderson, A. J., Tomasulo, P. A., Aster, R. H.: ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood 54, 59 (1979).
32. Office of Medical Applications of Research, National Institutes of Health: Platelet transfusion therapy. J. Am. Med. Assoc. 257, 1777-1780 (1987).
33. Heal, J. M., Rowe, J. M., McMican, A., Masel, D., Finke, C., Blumberg, N.: The role of ABO matching in platelet transfusion. Eur. J. Haematol. 50, 110-117 (1993).
34. Heal, J. M., Rowe, J. M., Blumberg, N.: ABO and platelet transfusion revisited. Ann. Hematol. 66, 309-314 (1993).
35. Benson, K., Fields, K., Hiemenz, J., Zorsky, P., Ballester, O., Perkins, J., Elfenbein, G.: The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding. Semin. Oncol. 20, 102-109 (1993).
36. Muylle, L., Joos, M., Wouters, E., de Bock, R., Peeterman, M. E.: Increased tumor necrosis factor α (TNFα), interleukin-1, and interleukin-6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 33, 195 (1993).
37. Nemo, G. J., McCurdy, P. R.: Prevention of platelet alloimmunization. (Editorial). Transfusion 31, 584 (1991).
38. Sugawara, S., Abo, T., Kumagai, K.: A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J. Immunol. Methods 100, 83-90 (1987).
39. Kurata, Y., Oshida, M., Take, H., Furubayashi, T., Nako, H., Tomiyama, Y., Kanayama, Y., Nagao, N., Okybo, Y., Yonezauia, T., Ttarui, S.: New approach to eliminate HLA class I antigens from platelet surface without cell damage; acid treatment at pH 3.0. Vox Sang. 57, 199-204 (1989).
40. Shanwell, A., Sallander, S., Olsson, I., Gulliksson, H., Pedajas, I., Lerner, R.: An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets. Br. J. Haematol. 79, 462-465 (1991).
41. Novotny, V. M. J., Huizinga, T. W. J., van Doorn, R., Briët, E., Brand, A.: HLA class I-eluted platelets as an alternative to HLA-matched platelets. Transfusion 36, 438-444 (1996).
42. Sirchia, G.: HLA-reduced platelets to overcome platelet refractoriness: can lemons help? (Editorial). Transfusion 36, 388-391 (1996).
43. Zeigler, Z. R., Shadduck, R. K., Rosenfeld, C. S., Winkelstein, A., Przepiorka, D., Kiss, J. E., Duquesnoy, R. J., Marrari, M.: Intravenous gamma globulin decreases platelet-associated IgG and improves transfusion responses in platelet refractory states. Am. J. Hematol. 38, 15 (1991).
44. Coller, B. S., Springer, K. T., Beer, J. H., Mohandas, N., Scudder, L. E., Norton, K. J., West, S. M.: Thromboerythrocytes: In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J. Clin. Invest. 89, 546 (1992).
45. Chao, F. C., Kimm, B. B., Houranieh, A. M., Liang, F. H., Tullis, J. L., Swisher, S. N., Kondrad, M.: Infusible platelet membrane (IPM) is a potential substitute for fresh platelets in transfusion: Correction of prolonged bleeding time in thrombocytopenic rabbits. Thromb. Haemostas. 69, 750 (1993).
46. Read, M. S., Reddick, R. L., Bode, A. P., Bellinger, D. A., Nichols, T. C., Taylor, K., Smith, S. V., McMahon, D. K., Griggs, T. R., Brinkhous, K. M.: Rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc. Nat. Acad. Sci. 92, 397 (1995).